Home » Lilly, Amylin Analysis Finds No Bydureon Effect on Heart Rhythm
Lilly, Amylin Analysis Finds No Bydureon Effect on Heart Rhythm
Amylin Pharmaceuticals Inc., Eli Lilly & Co., and Alkermes Inc. said an analysis of a 148-patient trial found no evidence that their experimental Bydureon diabetes drug causes prolonged heart rhythms.
Bloomberg
Bloomberg
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May